Targeted molecular therapy for myasthenia gravis

研究成果: Comment/debate › 査読

1 被引用数 (Scopus)

ASJC Scopus subject areas

@article{db849b3ae5184961b904cfd4677ad395,

title = "Targeted molecular therapy for myasthenia gravis",

author = "Shigeaki Suzuki",

year = "2021",

month = jul,

doi = "10.1016/S1474-4422(21)00173-3",

language = "English",

volume = "20",

pages = "499--500",

journal = "The Lancet Neurology",

issn = "1474-4422",

publisher = "Lancet Publishing Group",

number = "7",

}

TY - JOUR

T1 - Targeted molecular therapy for myasthenia gravis

AU - Suzuki, Shigeaki

PY - 2021/7

Y1 - 2021/7

UR - http://www.scopus.com/inward/record.url?scp=85107949787&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85107949787&partnerID=8YFLogxK

U2 - 10.1016/S1474-4422(21)00173-3

DO - 10.1016/S1474-4422(21)00173-3

M3 - Comment/debate

C2 - 34146498

AN - SCOPUS:85107949787

SN - 1474-4422

VL - 20

SP - 499

EP - 500

JO - The Lancet Neurology

JF - The Lancet Neurology

IS - 7

ER -